Osmotic laxatives (macrogol) draw water into the bowel and are well-tolerated for long-term use, making them suitable for chronic GLP-1 therapy
Because all of these organizations use WADA and USADA banned substances list, and BPC-157 is currently classified as Not FDA approved Classified as experimental Peptide with potential performance/recovery effects It will be interesting to see how this changes if/when it gets changed to Category 1, likely later this year by the FDA
After reaching the desired tone, maintenance sessions may be needed monthly or bi-monthly
Anticholinergic drugsused for overactive bladder, Parkinson's disease, or COPDdelay gastric transit time and can reduce semaglutide or tirzepatide oral bioavailability by 20-40%
Dazman18: Glutathione shows promise as a supportive therapy for Parkinsons by reducing oxidative damage, improving mitochondrial function, and possibly easing symptoms